Casino, Guichard-Perrachon SA : Close to a support level
Entry price | Target | Stop-loss | Potential |
---|
€38.18 |
€42.1 |
€35.9 |
+10.27% |
---|
The recently observed decline yields a good timing for new long positions close to the support level.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths● The share is getting closer to its long-term support in weekly data, at EUR 35.58, which offers good timing for buyers.
● Graphically speaking, the timing seems perfect for purchasing the stock close to the EUR 34.55 support.
● The company shows low valuation levels, with an enterprise value at 0.21 times its sales.
● With a P/E ratio at 11.71 for the current year and 10.8 for next year, earnings multiples are highly attractive compared with competitors.
● This company will be of major interest to investors in search of a high dividend stock.
● The stock is in a well-established, long-term rising trend above the technical support level at 35.58 EUR
Weaknesses● The company sustains low margins.
● Analysts covering the stock have recently lowered their earnings forecast.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.